Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sebazole is a topical medicated shampoo developed by Virbac for veterinary use in dogs and cats. It is a multi-component small molecule formulation containing econazole nitrate (10mg/mL), sulphur (as sodium thiosulphate), sodium salicylate (35mg/mL), and chloroxylenol (5mg/mL). The product is indicated for the treatment of keratinisation disorders such as seborrhoea, particularly when complicated by secondary bacterial (Staphylococcal) or yeast (Malassezia) overgrowth. It is also effective against fungal infections including ringworm (Microsporum and Trichophyton species) and pyoderma. The therapeutic effect is achieved through the antifungal activity of econazole, the antibacterial properties of chloroxylenol, and the keratolytic and keratoplastic actions of sulphur and sodium salicylate, which remove scales and crusts while enhancing the penetration of the antimicrobial agents.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sebazole.